# FDA recall D-1206-2018

> **Accord Healthcare, Inc.** · Class I · drug recall initiated 2018-08-21.

## Product

Hydrochlorothiazide Tablets USP, 12.5 mg, 100-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703; Manufactured by: Intas Pharmaceuticals Limited, Ahmedabad - 382 210, India; NDC 16729-182-01.

## Reason for recall

Product Mix-Up: customer complaint that a sealed bottle labeled as Hydrochlorothiazide Tablets USP 12.5 mg contained only Spironolactone Tablets USP 25 mg.

## Distribution

Nationwide in the USA and Puerto Rico.

## Key facts

- **Recall number:** D-1206-2018
- **Recalling firm:** Accord Healthcare, Inc.
- **Classification:** Class I
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2018-08-21
- **Report date:** 2018-09-19
- **Termination date:** 2020-05-07

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Durham, NC, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1206-2018

## Citation

> AI Analytics. FDA recall D-1206-2018. Retrieved 2026-06-08 from https://api.ai-analytics.org/recall/D-1206-2018. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*